Team:Aachen/Project/FRET Reporter
From 2014.igem.org
(→Cutting the Fusion Protein with the TEV Protease) |
(→Cutting the Fusion Protein with the TEV Protease) |
||
Line 34: | Line 34: | ||
==Cutting the Fusion Protein with the TEV Protease== | ==Cutting the Fusion Protein with the TEV Protease== | ||
- | As the protease, we chose Tobacco Etch Virus (TEV) protease, a highly sequence-specific cysteine protease, that is frequently used for the controlled cleavage of fusion proteins ''in vitro'' and ''in vivo''. The native protease also contains an internal self-cleavage site. This site is slowly cleaved to inactivate the enzyme. The physiological reason for the self-cleavage is unknown, however, undesired for our use. Therefore, our team | + | As the protease, we chose Tobacco Etch Virus (TEV) protease, a highly sequence-specific cysteine protease, that is frequently used for the controlled cleavage of fusion proteins ''in vitro'' and ''in vivo''. The native protease also contains an internal self-cleavage site. This site is slowly cleaved to inactivate the enzyme. The physiological reason for the self-cleavage is unknown, however, undesired for our use. Therefore, our team uses a variant of the native TEV protease that contains the mutation S219V which results in an alteration of the cleavage site so that self-inactivation is diminished. |
- | Though very popular, the TEV protease is not avaiable as a BioBrick yet. Hence, the Aachen team introduces | + | Though very popular, the TEV protease is not avaiable as a BioBrick yet. Hence, the Aachen team introduces a protease with anti-self cleavage mutation S219V and codon optimized for ''E. coli'' to the Parts Registry this year. |
{{Team:Aachen/BlockSeparator}} | {{Team:Aachen/BlockSeparator}} |
Revision as of 13:12, 6 October 2014
|
|
|
|
|